Companies processing cannabis-based medicines accidental U.S. moves to loosen restrictions connected the cause could unlock backstage backing and the nationalist markets, providing a lifeline to the struggling cannabis industry.
The U.S. Department of Justice past week rescheduled FDA-approved medicines and state-regulated aesculapian marijuana products, making it easier for companies to slope and person taxation credits and deductions.

1 month ago
1





